JY
EVGN icon

Jeff Yass’s Evogene EVGN Stock Holding History

Jeff Yass’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,000
Closed -$26K – 13300
2021
Q3 		$26K Sell
1,000
-510
-34% -$14.9K ﹤0.01% 12506
2021
Q2 		$52K Sell
1,510
-410
-21% -$16.1K ﹤0.01% 12289
2021
Q1 		$97K Buy
+1,920
New +$119K ﹤0.01% 11874

Other funds holding EVGN

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $137M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.45B AUM

Jeff Yass's EVGN Position: Q2 2026 in Review

Jeff Yass opened a new position in Evogene (EVGN) in Q2 2026: 80,078 shares worth $33.9K. The stake represents ﹤0.01% of the portfolio and ranks #12932 among its holdings. This is a return to the name: Jeff Yass previously reported a position in EVGN as recently as Q2 2024.

Jeff Yass first reported a position in EVGN in Q3 2020 and has held it in 13 quarters since. The position peaked at $287K in Q1 2021. 13 funds tracked by Wall St. Rank hold EVGN as of Q2 2026.

  • Jeff Yass held 80,078 shares of Evogene worth $33.9K as of Q2 2026.
  • Evogene was a new Jeff Yass position in Q2 2026.
  • Evogene made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12932 holding.
  • Jeff Yass first reported a position in Evogene in Q3 2020 and has held it in 13 quarters since.
  • Jeff Yass's Evogene position peaked at $287K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held Evogene as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.